Cluster analysis revealed divergent CXCL9 and KL-6 trajectories linked to disease outcomes, underscoring their value as dynamic, disease-specific biomarkers.<h4>Conclusion</h4>CXCL9 levels correlate with divergent roles in ILD and COPD. Here, CXCL9 is linked to interstitial lung disease.